Clinical Trial Update: A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies [Phase 2]

View source ↗

Summary

This Phase 2 trial investigates changes in disease activity and safety in adults with gynecologic cancers treated with IMGN151, either alone or in combination w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• IMGN151

Snippet

Sponsor: AbbVie | Conditions: Gynecologic Cancers, Platinum-Sensitive Ovarian Cancer | Phase 2 | Status: RECRUITING